Functional characterization of bradykinin analogues on recombinant human bradykinin B1 and B2 receptors

European Journal of Pharmacology

Volumn 392, Issue 1-2, 2000, Pages 1-9

  Simpson, Peter B ^a   Woollacott, Anthony J ^a   Hill, Raymond G ^a   Seabrook, Guy R ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Bradykinin; Ca2+; CHO cells; Des Arg10 kallidin; FLIPR (fluorometric imaging plate reader); Non competitive antagonism

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; CALCIUM ION; ICATIBANT; KALLIDIN; KALLIDIN[1-9]; LYSYLLYSYLARGINYLPROLYL(4 HYDROXYPROLYL)GLYCYL 2 (2,3 DIHYDRO 1H INDEN 2 YL)GLYCYLSERYL 2 (2,3 DIHYDRO 1H INDEN 2 YL)GLYCYLOCTAHYDRO 1H INDOLE 2 CARBOXYLIC ACID; RECEPTOR SUBTYPE; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; CALCIUM CELL LEVEL; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; FLUORESCENCE; IMAGING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRADYKININ; CALCIUM; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROMETRY; HUMANS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RECOMBINANT PROTEINS;

EID: 0034708421     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00046-7     Document Type: Article

References (35)

1. 2 receptors in the mouse. Can. J. Physiol. Pharmacol. 73:1995;1759-1764.
2. Andre M., Rahimi S., Schollmeyer P., Pavenstadt H. Bradykinin stimulates the intracellular calcium activity in human mesothelial cells. Nephrol., Dial., Transplant. 13:1998;247-2052.
3. 2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem. 270:1995;13706-13710.
4. Cuthbert A.W., MacVinish L.J., Pickles R.J. Antagonism of kinin effects on epithelia by Hoe140, apparently competitive and non-competitive interactions. Br. J. Pharmacol. 107:1992;797-802.
5. Dray A., Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
6. 2 bradykinin receptor activity determines the action of partial agonists as agonists or inverse agonists. J. Biol. Chem. 274:1999;29603-29606.
7. 2 receptor antagonist, Hoe140, in isolated blood vessels from different species. Br. J. Pharmacol. 112:1994;683-689.
8. A receptors containing γ3 subunits. Eur. J. Pharmacol. 291:1995;301-309.
9. Hall J.M. Bradykinin receptors. Gen. Pharmacol. 28:1997;1-6.
10. Hess J.F., Borkowski J.A., Young G.S., Strader C.D., Ransom R.W. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184:1992;260-268.
11. Hock T.J., Wirth K., Albus U., Linz W., Gerhards J.J., Wiemer G., Henke St., Breipohl G., Konig W., Knolle J., Scholkens B.A. Hoe140 a new potent and long acting bradykinin-antagonist, in vitro studies. Br. J. Pharmacol. 102:1991;769-773.
12. Kenakin T. Pharmacologic Analysis of Drug-Receptor Interaction. 2nd edn. 1993;Raven Press, New York.
13. Lembeck F., Giesbacher T., Legat F.J. Lack of significant unspecific effects of Hoe140 and other novel bradykinin antagonists in vitro and in vivo. Agents Actions Suppl. 38:1992;414-422.
14. 2-receptor-mediated positive chronotropic effect of bradykinin in isolated rat atria. J. Cardiovasc. Pharmacol. 32:1998;452-456.
15. 1 receptors. Can. J. Physiol. Pharmacol. 75:1997;735-740.
16. 1 receptors for kinins. Pharmacol. Rev. 50:1998;357-386.
17. 2 kinin receptor. J. Pharmacol. Exp. Ther. 289:1999;1250-1256.
18. 1 bradykinin receptor. J. Biol. Chem. 269:1994;21583-21586.
19. 1-histamine receptor antagonists in fluorescent imaging plate reader-based calcium assays. J. Biomol. Screening. 4:1999;249-258.
20. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br. J. Pharmacol. 110:1993;71-76.
21. 2 receptor, inter-species variability and dissociation between binding and functional responses. Br. J. Pharmacol. 126:1999;1083-1090.
22. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
23. 2 receptor subtype. Inflammation Res. 47:1998;231-235.
24. 2 receptor on nociception in rats and mice. Pain. 71:1997;89-97.
25. Sakamoto T., Sun J., Barnes P.J., Chung K.F. Effect of a bradykinin receptor antagonist, HOE140, against bradykinin- and vagal stimulation-induced airway responses in the guinea-pig. Eur. J. Pharmacol. 251:1994;137-142.
26. Santiago J.A., Osei S.Y., Kadowitz P.J. Inhibitory effects of Hoe140 on vasodilator responses to bradykinin in the mesenteric vascular bed of the cat. Eur. J. Pharmacol. 236:1993;315-318.
27. 2 receptor knockout mice. Neuropharmacology. 36:1997;1009-1017.
28. Seabrook G.R., Bowery B.J., Hill R.G. Bradykinin receptors in mouse and rat isolated superior cervical ganglia. Br. J. Pharmacol. 115:1995;368-372.
29. 2+ stores: activation and function. Trends Neurosci. 18:1995;299-306.
30. Stewart J.M., Gera L., Chan D.C., Whalley E.T., Hanson W.L., Zuzack J.S. Potent, long-acting bradykinin antagonists for a wide range of applications. Can. J. Physiol. Pharmacol. 75:1997;719-724.
31. Stewart J.M., Gera L., Hanson W., Zuzack J.S., Burkard M., McCullough R., Whalley E.T. A new generation of bradykinin antagonists. Immunopharmacology. 33:1996;51-60.
32. Whiting P., Schoepfer R., Lindstrom J., Priestley T. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol. Pharmacol. 40:1991;463-472.
33. Wirth K., Hock T.J., Albus U., Linz W., Alpermann H.G., Anagnostopoulos H., Henke St., Breipohl G., Konig W., Knolle J., Scholkens B.A. Hoe140 a new potent and long acting bradykinin-antagonist, in vivo studies. Br. J. Pharmacol. 102:1991;774-777.
34. 1 receptor antagonist. Agents Actions Suppl. 38:1992;406-413.
35. 1 kinin receptor expression and pharmacology in endothelial cells of different origins and species. J. Pharmacol. Exp. Ther. 280:1997;1109-1116.